Jagsonpal Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Last Friday at 10:00 AM
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
Key Metrics
PE ratio
30.19
PB ratio
4.84
Dividend yield
1.37%
Beta
-0.48
Market cap
₹12.27B
Enterprise value
₹10.49B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 1399 |
| Website | https://www.jagsonpal.com |
| Mailing address | Nimai Tower 3rd Floor Plot No. 412-415, Phase-IV Udyog Vihar Sec-18 Gurugram 122015 India |
| Phone / Fax | 91 12 4440 6710 / |
Dividends
Dividend yield
1.37%
Dividend amount
₹2.50
Payout ratio
41.25%
5Y Avg. yield
-%
Jagsonpal Pharmaceuticals Limited paid ₹2.50 dividend and the ex-dividend date was 12 Sep 2025.The dividend payout ratio is 41.25%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.JAGSNPHARM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Jagsonpal Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Manish Gupta | MD & Director | 58 | |
| Mr. Pratham Rawal | Company Secretary & Compliance Officer | ||
| Mr. Nirav Niranjanakumar Vora | Chief Financial Officer | ||
| Mr. Amrut Medhekar | Chief Operating Officer | ||
| Sudeep Paul | Vice President of Sales & Marketing | ||
| Mr. Bharat Chugh | General Manager of Human Resource Admin |
Profitability and management effectiveness
Profit margin
14.53%
Operating margin
19.03%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Jagsonpal Pharmaceuticals Limited is 12.27B and its enterprise value is 10.49B. The enterprise value to revenue ratio of JAGSNPHARM is 3.73. The enterprise value to EBITDA ratio of JAGSNPHARM is 18.24.
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Frequently Asked Questions
1. What is Jagsonpal Pharmaceuticals Limited's Stock Symbol?
Jagsonpal Pharmaceuticals Limited trades on NSE under the ticker symbol "JAGSNPHARM".
2. What is Jagsonpal Pharmaceuticals Limited's stock price today?
One share of JAGSNPHARM stock can currently be purchased for approximately ₹182.98.
3. How can I contact Jagsonpal Pharmaceuticals Limited?
Jagsonpal Pharmaceuticals Limited's mailing address is Nimai Tower 3rd Floor Plot No. 412-415, Phase-IV Udyog Vihar Sec-18 Gurugram 122015 India. The company can be reached via phone at 91 12 4440 6710.
4. What is Jagsonpal Pharmaceuticals Limited's official website?
The official website of Jagsonpal Pharmaceuticals Limited is https://www.jagsonpal.com.